Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 63-68, 2024.
Article in Chinese | WPRIM | ID: wpr-1005215

ABSTRACT

OBJECTIVE To evaluate the cost-effectiveness of ivabradine in the treatment of chronic heart failure (CHF) in the context of “Quadruple Therapy” from the perspective of the health system. METHODS Based on real-world cohort data, the Markov model was constructed according to the natural progression of CHF, with a cycle time of 3 months, a study timeframe of 20 years, and a discount rate of 5%. Using quality-adjusted life year (QALY) and incremental cost-effectiveness ratios (ICER) as the output indexes, the cost-utility analysis was used to evaluate the cost-effectiveness of ivabradine in combination with the “Quadruple Therapy” regimen, compared with the “Quadruple Therapy” regimen for the treatment of CHF, and the robustness of the results of the base analysis was verified by univariate sensitivity analysis and probabilistic sensitivity analysis. RESULTS The results of the base analysis showed that the ICER of ivabradine combined with the “Quadruple Therapy” regimen was 165 065.54 yuan/QALY, compared with the “Quadruple Therapy” regimen, which was lower than the willingness-to-pay (WTP) threshold (257 094 yuan/QALY) based on 3 times of China’s gross domestic product (GDP) per capita in 2022. The results of the univariate sensitivity analysis showed that the discount rate had the greatest impact on the robustness of the model. The probabilistic sensitivity analysis showed that the probability that the ivabradine combined with the “Quadruple Therapy” regimen was cost-effective under the WTP threshold in this study was 59.50%. CONCLUSIONS When using 3 times China’s 2022 GDP per capita (257 094 yuan/ QALY) as the WTP threshold, the combination of ivabradine and the “Quadruple Therapy” regimen for treating CHF is cost- effective.

2.
China Pharmacy ; (12): 1989-1994, 2023.
Article in Chinese | WPRIM | ID: wpr-980593

ABSTRACT

OBJECTIVE To analyze the research status and development trends of the use of sacubitril/valsartan. METHODS Related literature about the use of sacubitril/valsartan were retrieved from CNKI and the core database of Web of Science. CiteSpace 5.8.R3 software was used to analyze authors, countries/areas, institutions and keywords. RESULTS & CONCLUSIONS Totally 1 193 Chinese literature and 1 060 English literature were included. The number of literature increased, with numerous literature covering the United States (429), the United Kingdom (185) and China (184). ZHANG Jing (5) and Solomon S D (118) published the highest number of Chinese and English articles. The authors of Chinese literature had less cooperation while the authors of English literature were in close contact. Dept. of Cardiology in the First Affiliated Hospital of Zhengzhou University (9), Dept. of Cardiology in the Affiliated Hospital of Xuzhou Medical University (9) and Novartis AG (134) had the highest quantity of publications of Chinese and English literature. The institutions of Chinese literature had a small number of overall publications and less cooperation while the institutions of English literature were closely connected. The clinical efficacy of sacubitril/valsartan for heart failure, hypertension and their complications were research hotspots in Chinese and English literature. Chinese scholars and research teams need to strengthen cooperation and communication in the future, as well as conduct research from the perspectives of sacubitril/valsartan in the treatment of heart failure, hypertension and related complication, the improvement of oxidative stress, and the evaluation of the efficacy of combination therapy with dapagliflozin.

3.
Chinese Journal of Trauma ; (12): 1026-1033, 2021.
Article in Chinese | WPRIM | ID: wpr-909972

ABSTRACT

Objective:To investigate the therapeutic effect and possible mechanism of low intensity pulsed ultrasound(LIPUS)on painful gait in mice with Achilles tendon injury.Methods:Male C57BL/6 mice were selected to establish the Achilles tendon injury model by surgically full-thinkness tear of the right Achilles tendon. The mice were divided into Achilles tendon injury group and Achilles tendon injury+LIPUS group according to the random number table method,with 7 mice per group. The Catwalk gait analysis system was used to evaluate the gait function of the mice by measuring the following five parameters 14 days after operation,including print area,standing time,step cycle,max intensity and stride length. Morphological changes of the Achilles tendon were observed by HE staining. Immunofluorescence staining was used to detect the expression level of nitric oxide synthase(iNOS)in the Achilles tendon tissues. At the same time,Achilles tendon cells were isolated and cultured in vitro. The cells were induced by 100 ng/ml lipopolysaccharide(LPS)for 12 hours to establish in vitro model(LPS group),and treated with LIPUS(LPS+LIPUS group). The control group was set as well(without any treatment). The nuclear translocation of nuclear transcription factor-κB(NF-κB)P65 was detected by immunofluorescence staining,and the expression of iNOS and phosphorylation(p)-NF-κB p65 protein was detected by Western blotting. Results:Compared with Achilles tendon injury group[(0.14±0.10)cm 2],the print area of the affected limb in Achilles tendon injury+LIPUS group[(0.28±0.13)cm 2]was increased( P<0.05). Compared with Achilles tendon injury group[(0.11±0.04)seconds],the standing time of the affected limb in Achilles tendon injury+LIPUS group[(0.21±0.03)seconds]was increased( P<0.05). Compared with Achilles tendon injury group[(0.25±0.05)seconds],the step cycle of the affected limb in Achilles tendon injury+LIPUS group[(0.40±0.05)seconds]was increased( P<0.05). There was no significant difference in the max intensity and stride length between Achilles tendon injury group and Achilles tendon injury+LIPUS group( P>0.05). HE staining showed obvious hyperplasia of Achilles tendon tissues in Achilles tendon injury group,with loosely and randomly arranged fibers,accompanied by neovascularization and inflammatory cell infiltration. Achilles tendon injury+LIPUS group showed more orderly arranged fibers in Achilles tendon tissues,and the degree of neovascularization and inflammatory cell infiltration were reduced. Compared with Achilles tendon injury group[(5.70±0.81)%],the expression level of iNOS in Achilles tendon injury+LIPUS group[(2.84±0.94)%]was decreased 14 days after operation( P<0.05). Immunofluorescence results of Achilles tendon cells showed that NF-κB p65 protein entered the nucleus in LPS group compared with control group,and that LIPUS treatment inhibited nuclear translocation. In control group,Western blotting showed that iNOS was not expressed,and that the expression of phosphorylated NF-κB p65 was 0.63±0.16. Compared with control group,the expression levels of iNOS(0.99±0.22)and p-NF-κB P65(1.02±0.19)in LPS group were significantly increased( P<0.05). Compared with LPS group,the expression levels of iNOS(0.62±0.10)and p-NF-κB P65(0.65±0.21)in LPS+LIPUS group were decreased( P<0.05). Conclusion:LIPUS treatment can alleviate pain gait in mice with Achilles tendon injury and inhibit iNOS expression in vivo and in vitro,which may be related to inhibition of NF-κB signaling pathway.

SELECTION OF CITATIONS
SEARCH DETAIL